金陵药业
(000919)
| 流通市值：41.84亿 | | | 总市值：41.86亿 |
| 流通股本：6.22亿 | | | 总股本：6.22亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,584,435,886.72 | 768,671,414.38 | 3,197,324,288.02 | 2,380,142,974.77 |
| 营业总成本 | 1,527,401,598.14 | 747,885,190.74 | 3,159,275,152.03 | 2,318,855,766.79 |
| 其他经营收益 | | | | |
| 营业利润 | 72,237,718.63 | 35,069,187.03 | 69,238,916.33 | 89,602,810.98 |
| 利润总额 | 69,599,142.61 | 34,920,563.36 | 65,191,315.78 | 89,711,144.03 |
| 净利润 | 55,979,155.13 | 29,642,644.92 | 51,292,285.96 | 74,818,279.63 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | 0 | -75,520.53 | -75,520.53 |
| 综合收益总额 | 55,979,155.13 | 29,642,644.92 | 51,216,765.43 | 74,742,759.1 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,730,076,208.2 | 3,751,786,749.57 | 3,797,747,980.29 | 3,543,965,287.99 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,261,988,570.68 | 2,264,482,036.9 | 2,209,064,980.01 | 2,480,031,659.52 |
| 资产总计 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 |
| 流动负债: | | | | |
| 流动负债合计 | 967,097,637.52 | 955,286,952.32 | 975,949,164.33 | 960,668,321.51 |
| 非流动负债: | | | | |
| 非流动负债合计 | 209,451,169.9 | 209,165,185.98 | 208,770,520.28 | 216,225,910.96 |
| 负债合计 | 1,176,548,807.42 | 1,164,452,138.3 | 1,184,719,684.61 | 1,176,894,232.47 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,765,901,252.27 | 3,805,778,572.93 | 3,777,722,966.83 | 3,792,363,193.16 |
| 股东权益合计 | 4,815,515,971.46 | 4,851,816,648.17 | 4,822,093,275.69 | 4,847,102,715.04 |
| 负债和股东权益合计 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,754,051,487.05 | 763,187,319.12 | 3,299,466,083.25 | 2,455,304,723.81 |
| 经营活动现金流出小计 | 1,506,660,755.76 | 764,235,078.81 | 3,125,256,834.12 | 2,366,012,446.22 |
| 经营活动产生的现金流量净额 | 247,390,731.29 | -1,047,759.69 | 174,209,249.13 | 89,292,277.59 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 351,618,274.37 | 135,852,606.69 | 1,183,661,079.43 | 981,304,075.51 |
| 投资活动现金流出小计 | 682,253,632.45 | 440,917,674.45 | 1,493,067,056.59 | 1,565,094,086.64 |
| 投资活动产生的现金流量净额 | -330,635,358.08 | -305,065,067.76 | -309,405,977.16 | -583,790,011.13 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 0 | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 66,198,368.64 | 1,558,501.4 | 85,076,073.18 | 82,469,941.34 |
| 筹资活动产生的现金流量净额 | -66,198,368.64 | -1,558,501.4 | -85,076,073.18 | -82,469,941.34 |
| 汇率变动对现金及现金等价物的影响 | -32,399.24 | -6,356.94 | 8,450.56 | 10,367.79 |
| 现金及现金等价物净增加额 | -149,475,394.67 | -307,677,685.79 | -220,264,350.65 | -576,957,307.09 |
| 期末现金及现金等价物余额 | 1,211,628,222.1 | 1,053,425,930.98 | 1,361,103,616.77 | 1,004,410,660.33 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -149,475,394.67 | - | -220,264,350.65 | - |